iPSC & Neurodegeneration

Neurodegeneration is the progressive loss of structure or function of neurons, including neuronal death. Several diseases, including Alzheimer’s and Parkinson’s disease, occur as a result of neurodegeneration. This feed focuses on the utility of induced pluripotent stem cells in neurodegenerative disorders.

August 3, 2020
Open Access

Neuroinflammation and histone H3 citrullination are increased in X-linked Dystonia Parkinsonism post-mortem prefrontal cortex

Neurobiology of Disease
Tiziana PetrozzielloGhazaleh Sadri-Vakili
July 26, 2020
Preprint
Open Access

The AppNL-G-F mouse retina is a site for preclinical Alzheimer's disease diagnosis and research

BioRxiv : the Preprint Server for Biology
M. VandenabeeleLies De Groef
August 1, 2020
Review
Open Access

Midbrain Dopaminergic Neuron Development at the Single Cell Level: In vivo and in Stem Cells

Frontiers in Cell and Developmental Biology
Emilía Sif Ásgrímsdóttir, Ernest Arenas
August 3, 2020
Open Access

CD8+ T cells are increased in the subventricular zone with physiological and pathological aging

Aging Cell
Manuel Moreno-ValladaresAnder Matheu
August 4, 2020
Review
Open Access

Stem cell-based approaches: Possible route to hearing restoration?

World Journal of Stem Cells
María Beatriz Durán-Alonso
August 5, 2020

Dendrosomal nanocurcumin promotes remyelination through induction of oligodendrogenesis in experimental demyelination animal model

Journal of Tissue Engineering and Regenerative Medicine
Mahsa MotavafMohammad Javan
August 8, 2020
Open Access

The transcription factor PITX1 drives astrocyte differentiation by regulating the SOX9 gene

The Journal of Biological Chemistry
Jeong Su ByunBaek-Soo Han
July 30, 2020

Brain insulin resistance impairs hippocampal plasticity

Vitamins and Hormones
Matteo SpinelliClaudio Grassi
July 31, 2020

InsP7 is a small-molecule regulator of NUDT3-mediated mRNA decapping and processing-body dynamics

Proceedings of the National Academy of Sciences of the United States of America
Soumyadip SahuStephen B Shears
July 28, 2020
Open Access

Adipose-Derived Stem Cells Reduce Lipopolysaccharide-Induced Myelin Degradation and Neuroinflammatory Responses of Glial Cells in Mice

Journal of Personalized Medicine
Kateryna YatsenkoOleg Tsupykov
July 27, 2020
Open Access

Neural stem cell conditioned medium alleviates Aβ<sub>25-35</sub> damage to SH-SY5Y cells through the PCMT1/MST1 pathway

European Journal of Histochemistry : EJH
Guoyong JiaCongcong Sun
July 28, 2020
Review
Open Access

Microglia: Agents of the CNS Pro-Inflammatory Response

Cells
José A Rodríguez-GómezMiguel A Burguillos
August 7, 2020
Open Access

PSCs Reveal PUFA-Provoked Mitochondrial Stress as a Central Node Potentiating RPE Degeneration in Bietti's Crystalline Dystrophy

Molecular Therapy : the Journal of the American Society of Gene Therapy
Zhao ZhangQizhou Lian
July 31, 2020
Open Access

Modeling of Frontotemporal Dementia Using iPSC Technology

International Journal of Molecular Sciences
Minchul KimJihwan Song
August 2, 2020
Open Access

Stabilization of heterochromatin by CLOCK promotes stem cell rejuvenation and cartilage regeneration

Cell Research
Chuqian LiangGuang-Hui Liu
August 12, 2020
Open Access

Neural differentiation of canine mesenchymal stem cells/multipotent mesenchymal stromal cells

BMC Veterinary Research
Sonja Prpar MihevcGregor Majdič

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

© 2020 Meta ULC. All rights reserved
/feed-previews/ipsc-neurodegeneration/5ac32c43-8c8f-4498-9cf8-0f9ffcb5b66a